Erudio Healtherudio.com
Clinical trial · no report yet · Phase not applicable
SBRT-SG 05 trial: what clinicians have said so far
Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer
- NCT02192788 ↗
- Completed
- Grupo de Investigación Clínica en Oncología Radioterapia
- Focused size, estimated: 1–150 verified statements
We haven't built an HCP commentary report on SBRT-SG 05 (oligometastatic prostate cancer; tests a strategy, not a drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on SBRT-SG 05 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 3 posts on X |
The trial
ClinicalTrials.gov- Official title
- Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer
- Phase
- Phase not applicable
- Status
- Completed
- Conditions
- Oligometastatic Prostate Cancer
- Interventions
- Stereotactic Body Radiation Therapy for Oligometastases
- Arms
- SBRT · Experimental
- Enrollment
- 68
- Primary outcomes
- Number of patients without disease progression of prostate cancer treated by SBRT
- Sponsor
- Grupo de Investigación Clínica en Oncología Radioterapia
- Start
- Aug 2014
- Primary completion
- Jul 2021
- Results posted
- No
- Registry record
- NCT02192788 · updated Nov 19, 2021
Publications
linked from the registry- Conde-Moreno AJ, Lopez-Campos F, Hervas A, Morillo V, Mendez A, Puertas MDM, Valero-Albarran J, Gomez Iturriaga A, Rico M, Vazquez ML, Samper Ots PM, Perez-Romasanta LA, Pastor J, Ibanez C, Ferrer F, Zapatero A, Garcia-Blanco AS, Rodriguez A, Ferrer C. A Phase II Trial of Stereotactic Body Radiation Therapy and Androgen Deprivation for Oligometastases in Prostate Cancer (SBRT-SG 05). Pract Radiat Oncol. 2024 Sep-Oct;14(5):e344-e352. doi: 10.1016/j.prro.2024.04.022. Epub 2024 Jun 29. PubMed 38944806